Novo Nordisk A/S

(NYSE:NVO)

50.46

-0.64 (-1.25%)

2:24ET Delayed

Open
49.49
High
51.10
Low
49.18
Vol.
414.56K
Mkt Cap
30.99B
52Wk High
73.73
52Wk Low
41.90
Avg. Vol.
307.70K
P/E (Trailing)
14.41
Beta
0.68
Short %
—
Div. Yield
1.90%

Company Profile

Novo Nordisk A/S

Novo Alle

Bagsvaerd,

Dominican Republic - Map

Phone: (454) 444-8888

Fax: (454) 449-0555

Website: www.novonordisk.com

CEO: Lars Rebien Sorensen

Employees: 25,516

Sector: Healthcare

Industry Group: Drugs

Industry: Drug Manufacturers - Other

Mfr industrial enzymes & pharmaceuticals

A healthcare company, engaged in the discovery, development, manufacture and marketing of pharmaceutical products. It operates in two segments, Diabetes Care and Biopharmaceuticals.

Recent news for NVO

Recent opinions on NVO

No recent Opinions for NVO

Top members owning NVO

  • Top 50%

    ironellis

    ironellis

    -34.08%3m:

    -33.45%YTD:

  • Top 39%

    nwarrior

    nwarrior

    -27.69%3m:

    -27.69%YTD:

  • Top 4%

    ITGURU

    ITGURU

    -41.49%3m:

    -43.77%YTD:

Members owning NVO also own

WAG (33.33%), GE (33.33%), PFE (33.33%), DNA (33.33%), GENZ (33.33%)

Member sentiment: Neutral